723 related articles for article (PubMed ID: 25993023)
21. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis.
Benucci M; Saviola G; Baiardi P; Manfredi M; Sarzi-Puttini P; Atzeni F
Int J Immunopathol Pharmacol; 2011; 24(1):269-74. PubMed ID: 21496415
[TBL] [Abstract][Full Text] [Related]
23. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis.
Swart JF; van Dijkhuizen EHP; Wulffraat NM; de Roock S
Ann Rheum Dis; 2018 Mar; 77(3):336-342. PubMed ID: 29138257
[TBL] [Abstract][Full Text] [Related]
24. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
Aikawa NE; França IL; Ribeiro AC; Sallum AM; Bonfa E; Silva CA
Vaccine; 2015 Jan; 33(5):604-9. PubMed ID: 25554240
[TBL] [Abstract][Full Text] [Related]
25. Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.
Ramanan AV; Dick AD; Jones AP; McKay A; Williamson PR; Compeyrot-Lacassagne S; Hardwick B; Hickey H; Hughes D; Woo P; Benton D; Edelsten C; Beresford MW;
N Engl J Med; 2017 Apr; 376(17):1637-1646. PubMed ID: 28445659
[TBL] [Abstract][Full Text] [Related]
26. Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritis.
van Straalen JW; Akay G; Kouwenberg CV; de Roock S; Kalinina Ayuso V; Wulffraat NM; de Boer J; Swart JF
RMD Open; 2023 Apr; 9(2):. PubMed ID: 37094979
[TBL] [Abstract][Full Text] [Related]
27. Etanercept in methotrexate-resistant JIA-related uveitis.
Saeed MU; Raza SH; Goyal S; Cleary G; Newman WD; Chandna A
Semin Ophthalmol; 2014 Jan; 29(1):1-3. PubMed ID: 24175644
[TBL] [Abstract][Full Text] [Related]
28. Treatment strategies aiming at remission in early rheumatoid arthritis patients: starting with methotrexate monotherapy is cost-effective.
Schipper LG; Kievit W; den Broeder AA; van der Laar MA; Adang EM; Fransen J; van Riel PL
Rheumatology (Oxford); 2011 Jul; 50(7):1320-30. PubMed ID: 21371999
[TBL] [Abstract][Full Text] [Related]
29. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
Zulian F; Balzarin M; Falcini F; Martini G; Alessio M; Cimaz R; Cimino L; Zannin ME
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):821-5. PubMed ID: 20191477
[TBL] [Abstract][Full Text] [Related]
30. Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients.
Katayama K; Matsuno T
Mod Rheumatol; 2009; 19(5):513-21. PubMed ID: 19603251
[TBL] [Abstract][Full Text] [Related]
31. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.
Deitch I; Amer R; Tomkins-Netzer O; Habot-Wilner Z; Friling R; Neumann R; Kramer M
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):801-808. PubMed ID: 29455252
[TBL] [Abstract][Full Text] [Related]
32. Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha.
De Stefano R; Frati E; Nargi F; Baldi C; Menza L; Hammoud M; Galeazzi M
Clin Rheumatol; 2010 May; 29(5):517-24. PubMed ID: 20082236
[TBL] [Abstract][Full Text] [Related]
33. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis.
Tynjälä P; Lindahl P; Honkanen V; Lahdenne P; Kotaniemi K
Ann Rheum Dis; 2007 Apr; 66(4):548-50. PubMed ID: 17068061
[TBL] [Abstract][Full Text] [Related]
34. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
[TBL] [Abstract][Full Text] [Related]
35. Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents.
Russo RA; Katsicas MM
J Rheumatol; 2009 May; 36(5):1078-82. PubMed ID: 19435972
[TBL] [Abstract][Full Text] [Related]
36. Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany.
Heiligenhaus A; Klotsche J; Niewerth M; Horneff G; Ganser G; Haas JP; Minden K
Arthritis Res Ther; 2020 Apr; 22(1):81. PubMed ID: 32293540
[TBL] [Abstract][Full Text] [Related]
37. Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching.
Brunelli JB; Silva CA; Pasoto SG; Saa CGS; Kozu KT; Goldenstein-Schainberg C; Leon EP; Vendramini MBG; Fontoura N; Bonfa E; Aikawa NE
Clin Rheumatol; 2020 Feb; 39(2):515-521. PubMed ID: 31707543
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A
Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713
[TBL] [Abstract][Full Text] [Related]
39. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
Bulatović Ćalasan M; Vastert SJ; Scholman RC; Verweij F; Klein M; Wulffraat NM; Prakken BJ; van Wijk F
Rheumatology (Oxford); 2015 Sep; 54(9):1724-34. PubMed ID: 25877908
[TBL] [Abstract][Full Text] [Related]
40. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study.
Saurenmann RK; Levin AV; Feldman BM; Rose JB; Laxer RM; Schneider R; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):647-57. PubMed ID: 17265500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
